首页> 外文OA文献 >A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors

【2h】

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors

机译：在晚期实体瘤患者中以新配方皮下施用aflibercept（VEGF trap）的I期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andrea Wang-Gillam; William P. Tew; Mace L. Rothenberg; Jakob Dupont; Wendy Cooper; Lars Sternas; Giliane Buzenet; Jeffrey A. Sosman; David R. Spriggs; Albert Craig Lockhart;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors [J] . Andrea Wang-Gillam, William P. Tew, Mace L. Rothenberg, Investigational New Drugs . 2012,第5期

机译：在晚期实体瘤患者中以新制剂皮下施用aflibercept（VEGF trap）的I期研究
2. A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors. [J] . Andrea Wang-Gillam, William P Tew, Mace L Rothenberg, Investigational new drugs. . 2012,第5期

机译：在晚期实体瘤患者中以新配方皮下注射阿柏西普（VEGF捕集剂）的I期研究。
3. Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors. [J] . Tew WP, Gordon M, Murren J, Clinical cancer research: an official journal of the American Association for Cancer Research . 2010,第1期

机译：晚期实体瘤患者皮下注射阿柏西普的1期研究。
4. Pharmacokinetic study of a systemically administered novel liposomal Temoporfln formulation in an animal tumor model [C] . Jenny Svensson, Ann Johansson, Niels Bendsoe, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI; Progress in Biomedical Optics and Imaging; vol.8 no.4; Proceedings of SPIE-The International Society for Optical Engineering; vol.6427 . 2007

机译：在动物肿瘤模型中全身施用新型脂质体替莫泊芬制剂的药代动力学研究
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors [O] . Andrea Wang-Gillam, William P. Tew, Mace L. Rothenberg, -1

机译：在晚期实体瘤患者中以新制剂皮下施用aflibercept（VEGF trap）的I期研究
7. Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors [O] . W. P. Tew, M. Gordon, J. Murren, 2009

机译：阶段1研究AfliBercept皮下给药到高级实体肿瘤患者

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors

著录项

引文网络

相似文献

相关主题

期刊订阅